Activities per year
Abstract
Introduction: Colorectal cancer (CRC) prevention programmes using faecal immunochemical testing (FIT) in screening rely on colonoscopy for secondary and surveillance testing. Colonoscopy capacity is an important constraint. Some European programmes lack sufficient capacity to provide optimal screening intensity regarding age-ranges, intervals and FIT cut-offs. It is currently unclear how to optimise programmes within colonoscopy capacity constraints.
Design: Microsimulation modelling, using the MISCAN-Colon model was used to determine if more effective CRC screening programmes can be identified within constrained colonoscopy capacity. 525 strategies were modelled and compared, varying 3 key screening parameters; screening intervals; age-ranges and FIT cut-offs, including previously unevaluated 4- and 5-year screening intervals (using a lifetime-horizon and 100% adherence). Results were compared with the policy decisions taken in Ireland to provide CRC screening within available colonoscopy capacity. Outcomes estimated net costs, quality-adjusted-life-years and required colonoscopies. The optimal strategies within finite colonoscopy capacity constraints were identified.
Results: Combining a reduced FIT cut-off of 10µg Hb/g, an extended screening interval of 4 years and an age range of 60-72 years requires 6% fewer colonoscopies, reduces net costs by 23% while preventing 15% more CRC deaths and saving 16% more QALYs relative to a strategy (FIT 40µg Hb/g, 2-yearly, 60-70 years) approximating current policy.
Conclusion: Previously overlooked longer screening intervals may optimise cancer prevention with finite colonoscopy capacity constraints. Changes could save lives, reduce costs, and relieve colonoscopy capacity pressures. These findings are relevant to CRC screening programmes across Europe that employ FIT-based testing which face colonoscopy capacity constraints.
Design: Microsimulation modelling, using the MISCAN-Colon model was used to determine if more effective CRC screening programmes can be identified within constrained colonoscopy capacity. 525 strategies were modelled and compared, varying 3 key screening parameters; screening intervals; age-ranges and FIT cut-offs, including previously unevaluated 4- and 5-year screening intervals (using a lifetime-horizon and 100% adherence). Results were compared with the policy decisions taken in Ireland to provide CRC screening within available colonoscopy capacity. Outcomes estimated net costs, quality-adjusted-life-years and required colonoscopies. The optimal strategies within finite colonoscopy capacity constraints were identified.
Results: Combining a reduced FIT cut-off of 10µg Hb/g, an extended screening interval of 4 years and an age range of 60-72 years requires 6% fewer colonoscopies, reduces net costs by 23% while preventing 15% more CRC deaths and saving 16% more QALYs relative to a strategy (FIT 40µg Hb/g, 2-yearly, 60-70 years) approximating current policy.
Conclusion: Previously overlooked longer screening intervals may optimise cancer prevention with finite colonoscopy capacity constraints. Changes could save lives, reduce costs, and relieve colonoscopy capacity pressures. These findings are relevant to CRC screening programmes across Europe that employ FIT-based testing which face colonoscopy capacity constraints.
Original language | English |
---|---|
Journal | MDM Policy & Practice |
DOIs | |
Publication status | Published - 01 Jan 2022 |
Keywords
- Health economics
- Cancer
- Cancer screening
- Colorectal cancer
- Capacity
- optimize patient outcomes
- Cancer Prevention
- Ireland, North-South Cooperation
- All Ireland Cancer Consortium
- National Cancer Institute
- International Cancer Screening Network
- Memorial Sloan Kettering Cancer Center
Fingerprint
Dive into the research topics of 'Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?'. Together they form a unique fingerprint.-
Consultation Workshop, Irish Cancer Society and the National Screening Service
McFerran, E. (Invited speaker) & O'Mahony, J. F. (Invited speaker)
07 Oct 2019Activity: Talk or presentation types › Invited talk
-
Erasmus University Medical Center
McFerran, E. (Contributor) & O'Mahony, J. F. (Contributor)
06 Jun 2019Activity: Visiting an external institution types › Visiting an external academic institution
-
How Ireland’s Colorectal Screening Programme Could SAVE MORE LIVES, SAVE MONEY & Stay Within Existing Colonoscopy Capacity Limits: Evidence From The MISCAN Microsimulation Model
McFerran, E. (Advisor), O'Mahony, J. F. (Contributor), McVicar, D. (Advisor), Zauber, A. (Advisor), Kee, F. (Advisor) & Lansdorp_Vogelaar, I. (Advisor)
16 Nov 2018Activity: Talk or presentation types › Invited talk
Prizes
-
HSC R&D/National Cancer Institute Health Economics Fellowship
McFerran, E. (Recipient), 2014
Prize: Fellowship awarded competitively
Research output
- 1 Other contribution
-
Colorectal cancer screening within colonoscopy capacity constraints: can FIT-based programmes save more lives by trading-off more sensitive test cut-offs against longer screening intervals?
McFerran, E., O'Mahony, J. F., Naber, S., Sharp, L., Zauber, A. G., Lansdorp-Vogelaar, I. & Kee, F., 19 Dec 2020Research output: Other contribution
Open AccessFile126 Downloads (Pure)